| Update on restless legs syndrome: from mechanisms to treatment P Gonzalez-Latapi, R Malkani Current neurology and neuroscience reports 19, 1-12, 2019 | 83 | 2019 |
| Loss‐of‐function variants in HOPS complex genes VPS16 and VPS41 cause early‐onset dystonia associated with lysosomal abnormalities D Steel, M Zech, C Zhao, KES Barwick, D Burke, D Demailly, KR Kumar, ... Annals of Neurology, 2020 | 81 | 2020 |
| A review of the clinical evidence for complementary and alternative therapies in Parkinson’s disease D Bega, P Gonzalez-Latapi, C Zadikoff, T Simuni Current treatment options in neurology 16, 1-19, 2014 | 78 | 2014 |
| Cognitive impairment in Parkinson’s disease: epidemiology, clinical profile, protective and risk factors P Gonzalez-Latapi, E Bayram, I Litvan, C Marras Behavioral Sciences 11 (5), 74, 2021 | 67 | 2021 |
| Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force–an update LM Lange, P Gonzalez‐Latapi, R Rajalingam, MAJ Tijssen, ... Movement Disorders 37 (5), 905-935, 2022 | 65 | 2022 |
| Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single‐center cohort study M Carecchio, F Invernizzi, P Gonzàlez‐Latapi, C Panteghini, G Zorzi, ... Movement Disorders 34 (10), 1516-1527, 2019 | 63 | 2019 |
| Impulse control and related disorders in Mexican Parkinson's disease patients M Rodríguez-Violante, P González-Latapi, A Cervantes-Arriaga, ... Parkinsonism & Related Disorders 20 (8), 907-910, 2014 | 63 | 2014 |
| Factors associated with the quality of life of subjects with Parkinson's disease and burden on their caregivers M Rodríguez-Violante, A Camacho-Ordoñez, A Cervantes-Arriaga, ... Neurología (English Edition) 30 (5), 257-263, 2015 | 53 | 2015 |
| Non-dopaminergic treatments for motor control in Parkinson’s disease: an update P Gonzalez-Latapi, SS Bhowmick, G Saranza, SH Fox CNS drugs 34 (10), 1025-1044, 2020 | 37 | 2020 |
| Factores asociados a la calidad de vida de sujetos con enfermedad de Parkinson ya la carga en el cuidador M Rodríguez-Violante, A Camacho-Ordoñez, A Cervantes-Arriaga, ... Neurología 30 (5), 257-263, 2015 | 36 | 2015 |
| Emerging and converging molecular mechanisms in dystonia P Gonzalez-Latapi, N Marotta, NE Mencacci Journal of Neural Transmission 128 (4), 483-498, 2021 | 33 | 2021 |
| Comparing the accuracy of different smell identification tests in Parkinson’s disease: relevance of cultural aspects M Rodríguez-Violante, P Gonzalez-Latapi, A Camacho-Ordoñez, ... Clinical neurology and neurosurgery 123, 9-14, 2014 | 33 | 2014 |
| Caracterización de la enfermedad de Parkinson en México: estudio ReMePARK A Cervantes-Arriaga, M Rodríguez-Violante, M López-Ruiz, ... Gaceta médica de México 149 (5), 497-501, 2013 | 32 | 2013 |
| Is there a role for DAT-SPECT imaging in a specialty movement disorders practice? D Bega, P Gonzalez-Latapi, C Zadikoff, W Spies, T Simuni Neurodegenerative Diseases 15 (2), 81-86, 2015 | 26 | 2015 |
| Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystonia NE Mencacci, MM Brockmann, J Dai, S Pajusalu, B Atasu, J Campos, ... The Journal of Clinical Investigation 131 (7), 2021 | 23 | 2021 |
| Low specificity and sensitivity of smell identification testing for the diagnosis of Parkinson’s disease M Rodríguez-Violante, P Gonzalez-Latapi, A Camacho-Ordoñez, ... Arquivos de Neuro-psiquiatria 72, 33-37, 2014 | 21 | 2014 |
| Epigenetic clock acceleration is linked to age at onset of Parkinson's disease X Tang, P Gonzalez‐Latapi, C Marras, NP Visanji, W Yang, C Sato, ... Movement Disorders 37 (9), 1831-1840, 2022 | 18 | 2022 |
| MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia L Meng, P Isohanni, Y Shao, BH Graham, SE Hickey, S Brooks, ... Annals of neurology 89 (4), 828-833, 2021 | 17 | 2021 |
| α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders I Martinez-Valbuena, E Swinkin, E Santamaria, J Fernandez-Irigoyen, ... Acta Neuropathologica 144 (2), 167-185, 2022 | 15 | 2022 |
| Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial CG Patterson, E Joslin, AB Gil, W Spigle, T Nemet, L Chahine, ... Trials 23 (1), 855, 2022 | 14 | 2022 |
Amin Cervantes-ArriagaNational Institute of Neurology and NeurosurgeryVerified email at innn.edu.mx
